News
/ News, Research
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable anti-tumor immunity (Zippelius Lab)
Although immune checkpoint inhibitors (ICIs) have been a breakthrough in clinical oncology, these therapies often fail to produce durable responses in a significant proportion of patients. This lack of long-term efficacy may be attributed…
Department of Biomedicine Newsletter No. 4
We're pleased to announce the release of the fourth edition of our DBM newsletter. We hope you enjoy reading it!
/ News, Research
Emerging insights reveal that rare diseases may be more prevalent than previously thought (Recher Lab)
The DBM congratulates Professor Mike Recher and his team, along with Dr. Hiroyuki Yamamoto's group from the National Institute of Infectious Diseases in Tokyo, Japan, on their recent publication in The Journal of Allergy and Clinical…
/ News, Research
New vaccine concept against SARS-CoV-2 successfully tested
Researchers at the University of Basel have developed a new approach for a vaccine against COVID-19. This vaccine is based on a modified coronavirus that can enter body cells and trigger an effective immune response but cannot multiply in…